Fimmcyte
Therapeutics
Read more
An international research, innovation and entrepreneurship initiative in Denmark
Sponsored Tracks
Sponsored Tracks
Sponsored tracks
On this page, you can explore the sponsored tracks BII runs in collaboration with relevant industry collaborators. By collaborating with industrial players, BII extends its offerings to early-stage start-ups by providing even better access to commercial paths and industry-specific knowledge.
Special Funding Opportunity with Ferring
The Reproductive Medicine and Maternal Health Track
Through the Reproductive Medicine and Maternal Health Track, Ferring Pharmaceuticals A/S supports BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine. For applicants, this is a unique opportunity to get direct early access to extensive expertise and advice from a key industry player.
Funding opportunity: Venture Lab
Are you looking for funding and professional guidance for your early-stage life science start-up? The Venture Lab program combines business acceleration, scientific development, and team development and includes a EUR 500,000 risk-free convertible loan.
We are looking for projects with evidence-based ideas and a clear understanding of unique value propositions. Applicants can be early-stage startups or researchers looking to take their research to a translational stage and build a start-up.
Read more about the program and apply for Venture Lab here.
Our focus areas
We are looking for therapeutics, diagnostics, or device solutions within the following areas:
- Reproductive medicine related to the treatment of female infertility to increase the success rates of procedural-based treatment (IVF, IVM, ICSI), therapeutics/non-therapeutics to treat the underlying causes of infertility (including implantation failure or endometrial receptivity), and male infertility.
- PCOS and endometriosis
- Pregnancy-related complications, preeclampsia, and pre-term birth.
If your project does not fall under these topics, check out the other topics supported in our women’s health initiative here.
Supported projects
The women’s health start-up Fimmcyte has already been supported under this track. Fimmcyte seeks to cure endometriosis, starting with a first step toward non-hormonal treatment of late-stage endometriosis. Read more about the first Ferring-sponsored project here.
Developing the first disease-modifying treatment for endometriosis.
Mohaned Shilaih
CEO, Fimmcyte
“Working closely with Ferring’s experts and expertise will enable us to tailor our development path to the needs of the various stakeholders in the complex drug development journey towards a new solution for patients”
Trine Bartholdy
Chief Innovation Officer, BioInnovation Institute
“Combining BII’s already proven incubation expertise with the industrial expertise and deep insights that Ferring has within women’s health forms a very strong basis for supporting and accelerating our mission of getting more solutions on the market that address the high unmet needs of 50% of the world’s population”
